-
PBS Liposomes: Precision Controls for Macrophage Depletion A
2026-06-02
PBS Liposomes offer researchers a true negative control for macrophage depletion studies, ensuring that observed effects are due to active agents and not liposome delivery. Their blank, phosphate-buffered saline core enables rigorous experimental interpretation and reproducibility in in vivo and ex vivo macrophage assays.
-
Kaixin Jieyu Granule Modulates TLR4/PI3K/Akt Signaling in De
2026-06-01
Xu et al. elucidate how Kaixin Jieyu Granule (KJG) alleviates neuroinflammation-induced depressive-like behaviors by targeting the TLR4/PI3K/Akt/FOXO1 pathway. Their integrated pharmacology and experimental validation provide mechanistic insight for researchers studying depression, neuroinflammation, and targeted pathway modulation.
-
Targeting SARS-CoV-2 Nucleocapsid LLPS: Mechanistic Insights
2026-06-01
A recent study elucidates how the SARS-CoV-2 nucleocapsid protein undergoes RNA-driven liquid–liquid phase separation (LLPS), a process essential for viral replication. The paper demonstrates that (-)-gallocatechin gallate (GCG) disrupts this condensation, revealing a novel antiviral mechanism with broad research implications for phase separation biology.
-
Amiloride (MK-870) in Sodium Channel Research: Applied Workf
2026-05-31
Amiloride (MK-870) reshapes sodium channel and endocytosis studies with precision, offering robust inhibition of ENaC and uPAR. This article details stepwise workflows, troubleshooting, and actionable protocol parameters for reproducible results in cystic fibrosis and hypertension research.
-
Phosphatase Inhibitor Cocktail 3: Enabling Accurate Phosphop
2026-05-30
Explore how Phosphatase Inhibitor Cocktail 3 (100X in DMSO) empowers advanced phosphoprotein analysis by preserving phosphorylation states, with a deep dive into its unique mechanistic advantages for infection and cell signaling research.
-
Plk1 Regulation of p31comet in Mitotic Checkpoint Disassembl
2026-05-29
This study reveals how Polo-like kinase 1 (Plk1) phosphorylates p31comet, thereby suppressing its role in the disassembly of mitotic checkpoint complexes. The findings clarify a key regulatory mechanism preventing futile cycling of checkpoint assembly and disassembly, advancing understanding of mitotic progression and potential checkpoint-targeted interventions.
-
Pentoxifylline Suppresses Macrophage NO via cAMP Elevation
2026-05-29
This study demonstrates that pentoxifylline, a non-specific phosphodiesterase inhibitor, suppresses nitric oxide production and inducible nitric oxide synthase expression in activated macrophages by elevating intracellular cAMP. These findings clarify the mechanistic basis for pentoxifylline's anti-inflammatory and immunomodulatory actions and inform its use in models of NO-mediated immune responses.
-
AICAR: Advancing Mitochondrial Quality Control in Metabolic
2026-05-28
Explore how AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) enables advanced study of AMPK-driven mitochondrial quality control and skeletal muscle metabolism. This article uniquely connects mitophagy mechanisms with practical research protocols for metabolic disease.
-
Tolazoline: Experimental Workflows for α2-Adrenergic Antagon
2026-05-28
Tolazoline enables precise, reproducible modulation of α2-adrenergic receptor signaling and ATP-sensitive potassium channels in both airway smooth muscle and islet function studies. This guide details actionable protocols, troubleshooting strategies, and data-driven optimizations for advanced pharmacological research.
-
O-GlcNAcylation Regulates Ferroptosis and Syncytialization i
2026-05-27
This study uncovers a mechanistic link between O-GlcNAc protein modification and the regulation of ferroptosis and trophoblast syncytialization in preeclampsia through the HUWE1–TfR1 axis. The findings suggest that modulating O-GlcNAcylation could provide new strategies for understanding and potentially mitigating placental dysfunction in preeclamptic pregnancies.
-
H-89: Precision cAMP-Dependent Protein Kinase Inhibitor Work
2026-05-27
H-89 enables high-fidelity modulation of cAMP signaling, empowering researchers to dissect PKA-driven processes with nanomolar precision. Discover advanced protocols, troubleshooting intelligence, and actionable insights for integrating this selective inhibitor into cutting-edge metabolic and cell signaling studies.
-
SIS3 (Smad3 Inhibitor): Deepening Understanding of TGF-β Pat
2026-05-26
Explore how SIS3, a potent Smad3 inhibitor, uniquely advances fibrosis and cancer research through precise modulation of the TGF-β pathway. This article delivers advanced insights, protocol guidance, and practical assay considerations based on cutting-edge scientific discoveries.
-
AICAR for AMPK Activation: Workflows in Metabolic Disease Re
2026-05-26
AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) is pivotal for dissecting energy metabolism and inflammation in cellular and animal models. This guide delivers stepwise protocols, troubleshooting insights, and strategic applications for maximizing the impact of APExBIO's AICAR in advanced metabolic disease and cellular stress research.
-
PF-562271 HCl: Translating FAK/Pyk2 Inhibition into Immuno-O
2026-05-25
Explore how PF-562271 HCl, a leading FAK/Pyk2 inhibitor, bridges kinase signaling and immune modulation in cancer research. This in-depth article reveals underappreciated opportunities for translational studies and practical assay optimization.
-
Obacunone Induces Ferroptosis in Ovarian Cancer via Akt/p53
2026-05-25
This study demonstrates that obacunone, a citrus-derived compound, triggers ferroptosis and inhibits proliferation in ovarian cancer cells by modulating the Akt/p53 signaling pathway. The research provides mechanistic evidence that pharmacological activation of Akt with SC 79 can reverse obacunone’s effects, highlighting the centrality of Akt phosphorylation in ferroptosis regulation and suggesting new therapeutic avenues for targeting resistant ovarian cancers.
414 records 7/28 page Previous Next First page 上5页 678910 下5页 Last page